Andrew Steele went from Olympic sprinter to co-founder of DNAFit to CEO of Stride, and he thinks biological age testing is the "Wild West" of consumer health, with no standardized way to measure it.

Dr. Jeremy Koenig talks with Andrew Steele, Olympic bronze medalist and CEO of Stride, about why single-test health platforms leave people stuck self-triangulating their own data. Steele explains how Stride combines genomics, gut microbiome testing, and advanced blood work (75 to 100 biomarkers per draw) with human practitioner coaching to move consumer health from raw data toward accountable outcomes. He also details a recent grant from Innovate UK, the government's research and innovation arm, to help standardize biological age testing, and shares why Stride has seen over 90 percent member retention past the first year. What would it take for an entire industry built on dashboards to start taking ownership of results instead?

Andrew Steele is the co-founder and CEO of Stride, an Olympic bronze medalist in the 4x400m relay, and the former co-founder of DNAFit, which was acquired by Prenetics ahead of its NASDAQ IPO. Website: https://www.getstride.com/ | Instagram: @andrewsteele

Catch Andrew's first appearance on the show: https://podcasts.apple.com/us/podcast/episode-43-from-olympic-tracks-to-health-tech-with/id1738771019?i=1000686629712

LINKS:

https://www.drjeremykoenig.com/
https://www.instagram.com/drjeremykoenig/
https://www.youtube.com/@drjeremykoenig

Here's the link for this week's episode: https://drjeremykoenig.substack.com/.